Praxis Precision Medicines Inc. (PRAX): Price and Financial Metrics
GET POWR RATINGS... FREE!
PRAX Stock Price Chart Interactive Chart >
PRAX Price/Volume Stats
|Current price||$4.76||52-week high||$15.08|
|Prev. close||$4.51||52-week low||$1.48|
|Day high||$4.81||Avg. volume||2,037,794|
|50-day MA||$2.66||Dividend yield||N/A|
|200-day MA||$3.87||Market Cap||224.29M|
Praxis Precision Medicines Inc. (PRAX) Company Bio
Praxis Precision Medicines, Inc. is a clinical-stage genetic neuroscience company that develops therapies for patients and families affected by complex and debilitating brain disorders. The company was founded by Kiran Reddy, David Goldstein and Steven Petrou on September 22, 2015 and is headquartered in Cambridge, MA.
Most Popular Stories View All
PRAX Latest News Stream
|Loading, please wait...|
PRAX Latest Social Stream
View Full PRAX Social Stream
Latest PRAX News From Around the Web
Below are the latest news stories about PRAXIS PRECISION MEDICINES INC that investors may wish to consider to help them evaluate PRAX as an investment opportunity.
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
In the last trading session, 18.48 million shares of the Praxis Precision Medicines Inc. (NASDAQ:PRAX) were traded. Most recently the company’s share price was $3.56, and it changed around $0.6 or 20.27% from the last close, which brings the market valuation of the company to $139.52M. PRAX currently trades at a discount to its 52-week … Praxis Precision Medicines Inc. (NASDAQ: PRAX): Stock Forecast For 2023 Sees A A Decline Of -79.52% Read More »
U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.14% to 34,141.19 while the NASDAQ fell 0.40% to 10,956.69. The S&P 500 also fell, dropping, 0.45% to 3,965.34. Check This Out: Netflix To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Thursday Leading and Lagging Sectors Health care shares gained by 0.5% on Friday. Meanwhile, top gainers in the sector included Praxis Precision Medicines, Inc. (NASDAQ: PRAX ), up 45%, and Biomea Fusion, Inc. (NASDAQ: BMEA ), up 7%. In trading on Friday, financials shares fell by 1%. Top Headline Bank of America Corporation (NYSE: BAC ) reported better-than-expected earnings for its fourth quarter. Bank of America posted quarterly earnings of...
The share price of Praxis Precision Medicines Inc. (NASDAQ:PRAX) rose to $2.42 per share on Thursday from $2.26. While Praxis Precision Medicines Inc. has overperformed by 7.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PRAX fell by -87.02%, with highs and lows ranging from $20.60 […]
Clinical-stage biopharmaceutical company, Praxis Precision Medicines (PRAX) and UCB, a global biopharmaceutical company collaborate based upon Praxis’ PRAX-020 program, for the discovery…
PRAX Price Returns